Regarding 'Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth'

被引:0
|
作者
Deng, Zhuo [1 ,2 ]
Lu, Dan [1 ,2 ,3 ]
机构
[1] Subei Peoples Hosp, Dept Obstet & Gynaecol, Yangzhou, Jiangsu, Peoples R China
[2] Dalian Med Univ, Clin Coll 1, Dalian, Peoples R China
[3] Yangzhou Univ, Dept Obstet & Gynaecol, Coll Clin Med, Yangzhou 225001, Jiangsu, Peoples R China
关键词
D O I
10.1016/j.ejogrb.2022.02.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
引用
收藏
页码:246 / 246
页数:1
相关论文
共 50 条
  • [1] Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth
    Ning, Angela
    Vladutiu, Catherine J.
    Dotters-Katz, Sarah K.
    Goodnight, William H.
    Manuck, Tracy A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 217 (03) : 371.e1 - 371.e7
  • [2] Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention
    Manuck, Tracy A.
    Watkins, W. Scott
    Moore, Barry
    Esplin, M. Sean
    Varner, Michael W.
    Jackson, G. Marc
    Yandell, Mark
    Jorde, Lynn
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (04) : 321.e1 - 321.e21
  • [3] 17-alpha hydroxyprogesterone caproate for the prevention of preterm birth
    Gupta, Simi
    Roman, Ashley S.
    WOMENS HEALTH, 2012, 8 (01) : 21 - 30
  • [4] A chronicle of the 17-alpha hydroxyprogesterone caproate story to prevent recurrent preterm birth
    Nelson, David B.
    McIntire, Donald D.
    Leveno, Kenneth J.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : 175 - 186
  • [5] Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth
    Manuck, Tracy A.
    Esplin, M. Sean
    Biggio, Joseph
    Bukowski, Radek
    Parry, Samuel
    Zhang, Heping
    Huang, Hao
    Varner, Michael W.
    Andrews, William
    Saade, George
    Sadovsky, Yoel
    Reddy, Uma M.
    Ilekis, John
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2016, 214 (03)
  • [6] SMFM Statement: Use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth
    不详
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 223 (01) : B16 - B18
  • [7] Recurrent spontaneous preterm birth risk is not associated with 17-alpha hydroxyprogesterone caproate levels
    Downes, Katheryne L.
    Venkataramanan, Raman
    Caritis, Steve
    Elovitz, Michal A.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : S422 - S423
  • [8] Does 17-alpha Hydroxyprogesterone Caproate Prevent Recurrent Preterm Birth in Obese Women?
    Eke, Ahizechukwu C.
    OBSTETRICS AND GYNECOLOGY, 2016, 128 (02): : 403 - 404
  • [9] Does 17-alpha hydroxyprogesterone caproate prevent recurrent preterm birth in obese women?
    Heyborne, Kent D.
    Allshouse, Amanda A.
    Carey, J. Christopher
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 213 (06) : 844.e1 - 844.e6
  • [10] Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth: a case-control study
    Manuck, T. A.
    Watkins, W. S.
    Esplin, M. S.
    Biggio, J.
    Bukowski, R.
    Parry, S.
    Zhan, H.
    Huang, H.
    Andrews, W.
    Saade, G.
    Sadovsky, Y.
    Reddy, U. M.
    Ilekis, J.
    Yandell, M.
    Varner, M. W.
    Jorde, L. B.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 125 (03) : 343 - 350